Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Blood Test Developed for Ovarian Cancer Diagnosis

By LabMedica International staff writers
Posted on 22 Mar 2011
An immunoassay using monoclonal antibodies has been tested for use in a highly sensitive blood test for ovarian cancer. More...


The ovarian cancer antibodies are capable of distinguishing between ovarian cancer and benign tumors of the ovary with 100% specificity and no false positives.

A blinded study of several ovarian cancer monoclonal antibodies (MAbs) was conducted in the Department of Gynecological Oncology at the University Hospital Leuven, (Leuven, Belgium). The MAbs were tested against 54 different blood samples comprised of 17 patients with ovarian cancer, 5 patients with benign tumors of the ovaries, 24 healthy young females, and 8 males.

Three of the MAbs, used in the immunoassays, correctly identified 16 of the 17 ovarian cancers, with a diagnostic sensitivity of 94% and 100% correct classification of the benign tumors. The antibodies are produced by MabCure, Inc., (New York, NY, USA). The combination of highly specific antibodies coupled with large output form a library containing more than 30,000 hybridomas, enables the company's to select only a handful of the most highly specific monoclonal antibodies against unique tumor specific antigens (TSA) appearing on targeted cancer cells. The antibodies are directed against TSA, which are uniquely expressed on cancer cells, but not on normal cells.

Charles Tackney, PhD, the chief scientific officer at MabCure, said, "There is a critical need for new diagnostic tools which would allow physicians to quickly and reliably determine a patient's disease status. Our data has certainly generated much interest and promises to deliver on a much needed new medical diagnostic tool for oncologists." MabCure intends to expand on this study with a follow-on analysis of more than 100 blood samples from patients with ovarian cancer or benign tumors of the ovaries. The study was presented at the annual meeting of the Society of Gynecological Oncologists held in March 6-9, 2011, in Orlando (FL, USA).

Related Links:
University Hospital Leuven
MabCure
Society of Gynecological Oncologists


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
HPV Test
Allplex HPV28 Detection
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.